Update shared on 05 Nov 2025
Analysts have maintained their price target for Anand Rathi Wealth at ₹2,510, citing continued confidence in fundamental growth rates and profitability margins. This comes despite minor adjustments to the discount rate and future price-to-earnings assumptions.
What's in the News
- The Board of Directors declared the first interim dividend of INR 6.00 per equity share (120 percent of face value) for the 2025-26 financial year on October 13, 2025. (Company announcement)
- The dividend will be credited or dispatched within 30 days of declaration to shareholders recorded as of October 17, 2025. (Company announcement)
- The board meeting held on October 13, 2025 included approval of the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2025. (Company announcement)
Valuation Changes
- Consensus Analyst Price Target: Unchanged at ₹2,510.
- Discount Rate: Decreased slightly from 14.77 percent to 14.71 percent.
- Revenue Growth: Remained steady at 21.28 percent.
- Net Profit Margin: Stable at 35.11 percent.
- Future P/E: Marginally decreased from 45.57x to 45.50x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.